News | April 15, 2024
Novartis tender offer for MorphoSys commences
The offer price corresponds to a premium of 142% on the volume-weighted average price during the last three months
The offer price corresponds to a premium of 142% on the volume-weighted average price during the last three months
The company plans to add 1700 beds by FY27 through the organic route
The plan essentially was to separate Aster’s India and GCC businesses to unlock long-term value
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
The company's SaaS solutions are tailored to enhance accessibility, efficiency, and patient-centricity in healthcare operations
The company also plans to boost its India presence by adding 1,500 beds in the next 2-3 years
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
BioVaxys has been granted exclusivity while the parties work in good faith on the drafting of a definitive agreement
Funding round led by Sarissa Capital, includes Sun Pharma, Polaris Partners
Subscribe To Our Newsletter & Stay Updated
